Mesothelioma Guide, News and Information
Mesothelioma Prognosis News
2010-03-11
Mesothelioma Cancer Takes Life of Pro Football Hall of Famer Merlin OlsenAsbestos.com... with limited treatment options and a poor prognosis. After receiving a diagnosis, the average lifespan of a mesothelioma patient is four to 18 months. ...and more »
2010-03-10
Predicting Post-Surgery Survival for Mesothelioma PatientsMesotheliomaHelp.net (blog)Results from a new study indicate that an RNA molecule found in cancerous tissue may be useful in predicting a mesothelioma patient’s chances for survival ...
2010-03-04
Surviving MesotheliomaNew Mesothelioma Vaccine Appears SafeMesothelioma & Asbestos Awareness CenterThis trial would mark the first time dendritic-cell immunotherapy has been used in patients diagnosed with mesothelioma. While prognosis in those diagnosed ...New Mesothelioma Vaccine Appears SafeIndia Business Blog (blog)all 24 news articles »
2010-03-09
PR Web (press release)New Research May Help Predict Post-Surgery Survival Rate For Mesothelioma PatientsPR Web (press release)The researchers said further validation of the findings and follow-up research could provide insight for prognosis of mesothelioma in patients' potential ...
2010-03-08
Archive for March, 2010Asbestos.com... of new treatments, including a clinical trial on a vaccine that may significantly improve the prognosis of patients with malignant mesothelioma. ...and more »
2010-03-11
Chicago based Asbestos Litigation, Personal Injury Law Firm of Cooney Conway Launches New Website Dedicated to Helping Mesothelioma Victims
2010-03-09
New York attorney Joseph W. Belluck, who handles mesothelioma cases, says study may give patients and their families a more accurate prognosis of the disease and how post-surgical patients will likely respond.
2010-03-05
Dear Dr. Donohue: Please tell me about glaucoma - its cause,treatment and prognosis. How do you feel about laser treatment?What are the risks associated with that treatment?
2010-02-17
Researchers from Rosetta Genomics , in collaboration with investigators from New York University's Langone Medical Center, this week published data in Cancer Research demonstrating that a single microRNA, miR-29c*, could be used as a prognostic biomarker in patients with mesothelioma.
2010-02-19
Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announced today that the results of a joint study with the NYU Langone Medical Center were published online on February 16th, 2010, and are set to be published in the March 1st issue of the American Association for Cancer Research's journal, Cancer Research...
The-Mesothelioma-Guide.com
Mesothelioma Guide, News and Information
Sponsored Links
Site Info